Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06090578 · ClinicalTrials.gov registry record · NA
TabCAT Brain Health Assessment in Primary Care
A NA study of Mild Cognitive Impairment and Dementia, sponsored by University of California, San Francisco.
- Recruiting
- Registry status
- NA
- Development phase
- 180,000
- Enrollment target
- 1
- Study location
NCT06090578: Recruiting NA study of Mild Cognitive Impairment and Dementia, sponsored by University of California, San Francisco.
NCT06090578 is a NA study of Mild Cognitive Impairment and Dementia that is actively recruiting participants, run by University of California, San Francisco. The registered enrollment target is 180,000 participants, above the 392-participant average among 205 other Mild Cognitive Impairment trials with a reported enrollment target (45818% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06090578, a NA study of Mild Cognitive Impairment and Dementia, is actively recruiting participants, sponsored by University of California, San Francisco.
- RECRUITING
- Registry status
- NA
- Development phase
- 180,000 participants
- Enrollment target
- 1
- Study location
Study Summary
Efficient and user-friendly paradigms to detect cognitive impairment, including dementia are needed in primary care. The TabCAT Brain Health Assessment accurately detects cognitive impairment via an appealing tablet interface with automated scoring and EMR integration. This study will evaluate the effectiveness of the paradigm on detection rates and other brain health outcomes via a pragmatic cluster randomized trial in 26 Kaiser Southern California primary care clinics.
Primary Outcome
Rate is out of all patients with an encounter during the steady state period at the clinic. The primary analyses for all outcomes are limited to ages 65+.
Conditions Studied
Interventions
- OTHER TabCAT Brain Health Assessment Clinical Pathway
Study Locations (1)
California
- Kaiser Permanente Southern California Department of Research & Evaluation - Pasadena
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 180,000 participants |
| Start Date | 2023-07-27 |
| Est. Completion | 2026-12-31 |
| Phase | NA |
What NCT06090578 shows while recruiting
NCT06090578 is an interventional study that assigns participants to a tested intervention. Its 180,000 participants enrollment target places it among the larger protocols in the corpus, above the 392-participant average among 205 other Mild Cognitive Impairment trials with a reported enrollment target (45818% higher).
The record links to 2 conditions, with Mild Cognitive Impairment appearing as the primary indexed condition, and to 1 intervention - of which TabCAT Brain Health Assessment Clinical Pathway is the first listed.
NCT06090578 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT06090578 about?
NCT06090578 is a clinical study titled "TabCAT Brain Health Assessment in Primary Care". Efficient and user-friendly paradigms to detect cognitive impairment, including dementia are needed in primary care. The TabCAT Brain Health Assessment accurately detects cognitive impairment via an appealing tablet interface with automated scoring and EMR integration. This study will evaluate the e...
What is the current status of trial NCT06090578?
This trial is currently recruiting. It is a NA study. The enrollment target is 180,000 participants. The study started on 2023-07-27. Estimated completion is 2026-12-31.
What conditions does trial NCT06090578 study?
This clinical trial studies the following conditions: Mild Cognitive Impairment, Dementia.
What interventions are being tested in trial NCT06090578?
The interventions under investigation include: TabCAT Brain Health Assessment Clinical Pathway (OTHER).
Who is sponsoring clinical trial NCT06090578?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06090578 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Mild Cognitive Impairment
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06090578's enrollment target sits among peer trials
180,000 1st of 205 higher than 205 of 205 other Mild Cognitive Impairment trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Mild Cognitive Impairment trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Wayfinding Intervention and Long-Term Memory
RECRUITING · NA
-
Dual Task Perturbation Training for OAwMCI
RECRUITING · NA
-
Impact of Intensive Computerized Cognitive Training
RECRUITING · NA
-
Multimodal Investigation of Neural Plasticity
RECRUITING · NA
-
GAMES Intervention in MCI (Mild Cognitive Impairment)
RECRUITING · NA
-
A Feasiblity Study of Green Activity Program for People Living With Memory Challenges
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06917339 · 156,000 participants
Retrospective Analyses of TrakStar Database
- NCT06232551 · 152,000 participants · NA
Alerting Providers at Patient Hospital Discharge to Consider Prescribing Rivaroxaban to Reduce Venous Thromboembolism
- NCT05994482 · 130,000 participants
Surveillance Colonoscopy in Older Adults: The SurvOlderAdults Study
- NCT02693509 · 128,026 participants
Get With The Guidelines-Heart Failure Registry
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI